drugset / Trial / NCT01999179
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Completed
27 enrolled
Medical College of Wisconsin
Ohio State University · collabVersiti Blood Health · collab
NaSingle-groupOpen-labelHealth-services research
Summary
The goal of the pilot study is to determine if a multicenter prospective cohort study of cancer patients with blood clots associated with catheters is feasible. Cancer patients with catheter-related thrombosis treated with one month of anticoagulation will be evaluated for for post-thrombotic syndrome. Laboratory biomarkers will be evaluated as predictors of recurrent thrombosis.
Timeline
- Start
- 2014-06
- Primary completion
- 2019-04-02
- Completion
- 2022-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Apixaban | Small molecule | — | Oral |
| Background | Dabigatran | Unknown | — | Oral |
| Background | Edoxaban | Small molecule | — | Oral |
| Background | Enoxaparin sodium | Other / unclassified | 1 mg/kg | Subcutaneous |
| Background | Rivaroxaban | Other / unclassified | — | Oral |